PT2967013T - Murganhos que expressam um repertório limitado de cadeia leve de imunoglobulina - Google Patents

Murganhos que expressam um repertório limitado de cadeia leve de imunoglobulina

Info

Publication number
PT2967013T
PT2967013T PT14717331T PT14717331T PT2967013T PT 2967013 T PT2967013 T PT 2967013T PT 14717331 T PT14717331 T PT 14717331T PT 14717331 T PT14717331 T PT 14717331T PT 2967013 T PT2967013 T PT 2967013T
Authority
PT
Portugal
Prior art keywords
light chain
immunoglobulin light
mice expressing
chain repertoire
limited immunoglobulin
Prior art date
Application number
PT14717331T
Other languages
English (en)
Portuguese (pt)
Inventor
J Murphy Andrew
Davis Samuel
R Buckler David
Mcwhirter John
A Meagher Karolina
Babb Robert
Macdonald Lynn
Stevens Sean
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/798,455 external-priority patent/US9796788B2/en
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of PT2967013T publication Critical patent/PT2967013T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • C07K16/468Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT14717331T 2013-03-13 2014-03-13 Murganhos que expressam um repertório limitado de cadeia leve de imunoglobulina PT2967013T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/798,455 US9796788B2 (en) 2010-02-08 2013-03-13 Mice expressing a limited immunoglobulin light chain repertoire

Publications (1)

Publication Number Publication Date
PT2967013T true PT2967013T (pt) 2019-04-03

Family

ID=50483561

Family Applications (2)

Application Number Title Priority Date Filing Date
PT14717331T PT2967013T (pt) 2013-03-13 2014-03-13 Murganhos que expressam um repertório limitado de cadeia leve de imunoglobulina
PT182105189T PT3501272T (pt) 2013-03-13 2014-03-13 Murganhos que expressam um repertório limitado de cadeia leve de imunoglobulina

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT182105189T PT3501272T (pt) 2013-03-13 2014-03-13 Murganhos que expressam um repertório limitado de cadeia leve de imunoglobulina

Country Status (26)

Country Link
EP (4) EP3501272B1 (https=)
JP (4) JP6529957B2 (https=)
KR (2) KR102424756B1 (https=)
CN (2) CN105188357B (https=)
AU (3) AU2014244020B2 (https=)
BR (1) BR112015022034B1 (https=)
CA (1) CA2903698C (https=)
CY (1) CY1121545T1 (https=)
DK (2) DK2967013T3 (https=)
ES (3) ES2712207T3 (https=)
FI (1) FI3501272T3 (https=)
HR (2) HRP20230490T1 (https=)
HU (2) HUE061977T2 (https=)
IL (2) IL240563B (https=)
LT (2) LT2967013T (https=)
MX (3) MX391010B (https=)
PL (2) PL3501272T3 (https=)
PT (2) PT2967013T (https=)
RS (2) RS64185B1 (https=)
RU (1) RU2689664C2 (https=)
SG (2) SG10201801101QA (https=)
SI (2) SI3501272T1 (https=)
SM (2) SMT201900196T1 (https=)
TR (1) TR201901668T4 (https=)
WO (1) WO2014160202A1 (https=)
ZA (2) ZA201505835B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2501817T2 (sl) 2010-02-08 2021-09-30 Regeneron Pharmaceuticals, Inc. Miš z navadno lahko verigo
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
RS59728B1 (sr) 2011-08-05 2020-02-28 Regeneron Pharma Humanizovani miševi univerzalnog lakog lanca
KR20160098514A (ko) 2011-10-17 2016-08-18 리제너론 파아마슈티컬스, 인크. 제한된 면역글로불린 중쇄 마우스
PT3597037T (pt) 2012-06-12 2021-06-01 Regeneron Pharma Animais não humanos humanizados com lócus de cadeia pesada de imunoglobulina restrito
EP2840892B1 (en) * 2013-02-20 2018-04-18 Regeneron Pharmaceuticals, Inc. Non-human animals with modified immunoglobulin heavy chain sequences
KR102276752B1 (ko) 2014-03-21 2021-07-13 리제너론 파마슈티칼스 인코포레이티드 단일 도메인 결합 단백질을 생산하는 비-인간 동물
EP3271403A1 (en) 2015-03-19 2018-01-24 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
AU2017206785C1 (en) 2016-01-13 2023-09-07 Regeneron Pharmaceuticals, Inc. Rodents having an engineered heavy chain diversity region
MY199789A (en) * 2017-09-29 2023-11-23 Regeneron Pharma Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof
IL318469A (en) 2018-06-14 2025-03-01 Regeneron Pharma Non-human animals capable of reorganizing transgenic DH-DH, and their uses
WO2020132557A1 (en) * 2018-12-21 2020-06-25 Compass Therapeutics Llc Transgenic mouse expressing common human light chain
EP3927832A4 (en) 2019-02-18 2022-11-30 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. GENETICALLY MODIFIED NON-HUMAN ANIMALS WITH HUMANIZED IMMUNOGLOBULIN LOCUS
JP2022520819A (ja) 2019-02-22 2022-04-01 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 遺伝子改変ナトリウムチャネルを有する齧歯類およびその使用方法
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
KR20230018439A (ko) 2020-06-02 2023-02-07 바이오사이토젠 파마슈티컬스 (베이징) 컴퍼니 리미티드 공동 경쇄 면역글로불린 좌위를 갖는 유전자 변형 비인간 동물
TW202242114A (zh) 2020-12-23 2022-11-01 美商再生元醫藥公司 用於獲得結合至跨膜蛋白之抗體以及抗體生成細胞的方法
CA3165366A1 (en) 2020-12-23 2022-06-30 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
CN114736927A (zh) * 2022-05-19 2022-07-12 东北大学 一种单抗克隆与表达载体的构建及应用
TW202430641A (zh) * 2023-01-18 2024-08-01 美商基利科學股份有限公司 人類免疫球蛋白二元輕鏈轉殖基因構築體及其用途
WO2026019824A1 (en) * 2024-07-16 2026-01-22 Gilead Sciences, Inc. Human immunoglobulin common light chain transgene constructs and uses thereof
CN121628915A (zh) * 2024-08-29 2026-03-10 上海泰槿生物技术有限公司 产生限制的免疫球蛋白轻链库的细胞、动物和方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041871B1 (en) 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7217797B2 (en) 2002-10-15 2007-05-15 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
EP1644417B1 (en) * 2003-07-15 2014-04-30 Therapeutic Human Polyclonals, Inc. Humanized immunoglobulin loci
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
AU2007235496B2 (en) * 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
ES2398076T3 (es) 2006-06-02 2013-03-13 Regeneron Pharmaceuticals, Inc. Anticuerpos de alta afinidad contra el receptor de IL-6 humano
ITMI20071522A1 (it) 2007-07-27 2009-01-28 Areta Internat S R L Vaccino idiotipico
PL3456190T3 (pl) 2008-06-27 2022-06-06 Merus N.V. Wytwarzające przeciwciała transgeniczne zwierzę z gatunku myszy
JP5827127B2 (ja) * 2008-12-18 2015-12-02 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム ヒト化抗体を発現する非ヒトトランスジェニック動物及びその使用
JP5816170B2 (ja) 2009-06-26 2015-11-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体
US20130045492A1 (en) * 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
SI2501817T2 (sl) * 2010-02-08 2021-09-30 Regeneron Pharmaceuticals, Inc. Miš z navadno lahko verigo
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
US9012717B2 (en) * 2010-06-22 2015-04-21 Regeneron Pharmaceuticals, Inc. Human lambda light chain mice
SG10201912639SA (en) * 2010-08-02 2020-02-27 Regeneron Pharma Mice that make binding proteins comprising vl domains
RU2460287C1 (ru) * 2011-03-29 2012-09-10 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Трансгенная мышь, предназначенная для моделирования состояний, угрожающих развитием синдрома внезапной сердечной смерти при дистрофин-дефицитной кардиомиопатии
RS59728B1 (sr) * 2011-08-05 2020-02-28 Regeneron Pharma Humanizovani miševi univerzalnog lakog lanca
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals

Also Published As

Publication number Publication date
IL280892B1 (en) 2023-01-01
EP3501272A1 (en) 2019-06-26
ES2712207T3 (es) 2019-05-09
CA2903698A1 (en) 2014-10-02
HUE061977T2 (hu) 2023-09-28
JP2019213549A (ja) 2019-12-19
CN105188357B (zh) 2018-04-24
EP4218409A3 (en) 2023-08-30
JP6790136B2 (ja) 2020-11-25
HRP20230490T1 (hr) 2023-08-04
KR102424756B1 (ko) 2022-07-25
AU2020203238B2 (en) 2023-04-13
MX377146B (es) 2025-03-07
CN108611369A (zh) 2018-10-02
EP3501272B1 (en) 2023-03-01
ES2942413T3 (es) 2023-06-01
LT3501272T (lt) 2023-03-27
KR20210107911A (ko) 2021-09-01
DK3501272T5 (da) 2024-09-02
MX357308B (es) 2018-07-04
AU2014244020B2 (en) 2020-06-04
EP4218409B1 (en) 2025-02-12
SG11201506278RA (en) 2015-09-29
FI3501272T3 (fi) 2023-04-06
EP4545567A3 (en) 2025-08-13
ES3013063T3 (en) 2025-04-10
JP6529957B2 (ja) 2019-06-12
IL280892B2 (en) 2023-05-01
AU2014244020A1 (en) 2015-09-24
DK2967013T3 (en) 2019-03-11
KR20150126871A (ko) 2015-11-13
RU2019115237A (ru) 2019-06-11
TR201901668T4 (tr) 2019-02-21
AU2023202783A1 (en) 2023-05-25
EP2967013B1 (en) 2019-01-16
IL240563A0 (en) 2015-09-24
RU2689664C2 (ru) 2019-05-28
NZ711776A (en) 2021-09-24
KR102295842B1 (ko) 2021-08-31
CY1121545T1 (el) 2020-05-29
ZA201505835B (en) 2019-09-25
IL280892A (en) 2021-04-29
JP2019076109A (ja) 2019-05-23
HK1218493A1 (en) 2017-02-24
MX391010B (es) 2025-03-21
LT2967013T (lt) 2019-04-25
WO2014160202A4 (en) 2014-11-13
MX2020010837A (es) 2022-03-28
EP4218409C0 (en) 2025-02-12
HRP20190706T1 (hr) 2019-10-18
JP2020182490A (ja) 2020-11-12
RU2015143110A (ru) 2017-04-18
RS58669B1 (sr) 2019-06-28
JP7010902B2 (ja) 2022-02-10
PL3501272T3 (pl) 2023-07-03
IL240563B (en) 2021-03-25
MX2015012539A (es) 2016-06-28
BR112015022034A2 (pt) 2017-08-29
JP2016512034A (ja) 2016-04-25
SI2967013T1 (sl) 2019-03-29
EP4218409A2 (en) 2023-08-02
DK3501272T3 (da) 2023-04-03
WO2014160202A1 (en) 2014-10-02
EP2967013A1 (en) 2016-01-20
SG10201801101QA (en) 2018-04-27
SI3501272T1 (sl) 2023-05-31
BR112015022034B1 (pt) 2023-02-28
AU2023202783B2 (en) 2026-02-12
PT3501272T (pt) 2023-03-29
PL2967013T3 (pl) 2019-07-31
HUE044003T2 (hu) 2019-09-30
CN108611369B (zh) 2022-08-26
ZA201805369B (en) 2021-08-25
CN105188357A (zh) 2015-12-23
SMT202300112T1 (it) 2023-05-12
AU2020203238A1 (en) 2020-06-11
CA2903698C (en) 2023-02-28
EP4545567A2 (en) 2025-04-30
SMT201900196T1 (it) 2019-05-10
RS64185B1 (sr) 2023-05-31

Similar Documents

Publication Publication Date Title
IL280892A (en) Mice expressing a restricted immunoglobulin light chain repertoire
IL240562A0 (en) A mouse with a common light chain
HUE041878T2 (hu) Humanizált fõ hisztokompatibilitási komplexet expresszáló egerek
GB2521962B (en) A light fitting
GB2520939B (en) A Platform
PL3033745T3 (pl) Urządzenie oświetleniowe
GB201312495D0 (en) A capo
DE112014004310A5 (de) Kettenführungselement
DE112014004457A5 (de) Kettenführungselement
GB201305228D0 (en) A Chain
GB201304231D0 (en) A Chain
GB201300689D0 (en) A Chain
GB2512339B (en) A capo
FR3003924B1 (fr) Transmission a variation continue
UY4363S (es) Configuración ornamental aplicada a un envase
UY4364S (es) Configuración ornamental aplicada a un envase
UY4362S (es) Configuración ornamental aplicada a un envase
FI20155875L (fi) Prosessi hiilivetyjen valmistamiseksi
ZA201404694B (en) A traffic light
GB201302164D0 (en) A sheath
TH148594B (th) เชนไกด์
FR3011726B3 (fr) Un grille-pain
UA27340S (uk) Балончик для соски-пустушки